Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in April 2026 (Volume 30, Issue 1) Submit manuscript

Clostridioides (Clostridium) difficile infection: Review of literature

Breadcrumb

  • Home
  • Clostridioides (Clostridium) difficile infection: Review of literature

George Trad 1, 5, 6, *, Varun Sodhi 2, 5, 6, Matthew Brockway 3, 5, 6, Nazanin Sheikhan 1, 5, 6, Abdul Gader Gheriani 2, 5, 6, Olivia Astor 1, 5, 6 and Hatim Gemil 4, 5, 6

1 PGY2, Department of Internal Medicine Sunrise Health GME Consortium 2880 N Tenaya Way 2nd Floor Las Vegas, NV, USA.
2 PGY3, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA 3PGY1, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA.
3 PGY1, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA.
4 Faculty Attending, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA.
5 Mountain View Medical Center.
6 HCA Healthcare, Nashville TN.
 
Review Article
World Journal of Advanced Research and Reviews, 2022, 14(02), 146-155
Article DOI: 10.30574/wjarr.2022.14.2.0366
DOI url: https://doi.org/10.30574/wjarr.2022.14.2.0366
 
Received on 22 March 2022; revised on 26 April 2022; accepted on 28 April 2022
 
Clostridioides (Clostridium) difficile (C. difficile) is a gram-positive bacterium that infects the large intestine. The number of clostridium difficile infections has increased in the recent years due to multiple risk factors including frequent use of antibiotics and proton pump inhibitors. The virulence of C. difficile comes from its production of toxins. Treatment for C. difficile infection includes the use of antibiotics, monoclonal antibodies, or a fecal transplant.
 
Clostridioides Difficile; Clostridium difficile; Antibiotics; Toxin; Diagnosis; Treatment; Monoclonal Antibodies
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2022-0366.pdf

Preview Article PDF

George Trad, Varun Sodhi, Matthew Brockway, Nazanin Sheikhan, Abdul Gader Gheriani, Olivia Astor and Hatim Gemil. Clostridioides (Clostridium) difficile infection: Review of literature. World Journal of Advanced Research and Reviews, 2022, 14(2), 146-155. Article DOI: https://doi.org/10.30574/wjarr.2022.14.2.0366

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution